Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
Most published data on the use of stereotactic body radiation therapy (SBRT; CyberKnife radiation therapy) has been based on a total radiation dose of 32 to 38 Gy delivered in a series of four or five sessions — as compared to the delivery of more like 75 to 80 Gy using intensity-modulated radiation (IMRT) and [...]
Filed under: Management, Treatment | Tagged: CyberKnife, dose, escalation, outcome, SBRT, stereotactic body radiation therapy | 2 Comments »
A story on the Bloomberg.com web site gives information about a patient with castration-resistant prostate cancer (CRPC) who has had a zero-level PSA for 40 months since starting on a clinical trial of abiraterone actetate in early 2008.
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: abiraterone, CRPC, orteronel, survival, TAK-700 | 3 Comments »
A new report from researchers at The Cleveland Clinic provides information on the association between statin use and prostate cancer in men who received a prostate biopsy between 2000 and 2007.
Filed under: Diagnosis, Prevention, Risk | Tagged: biopsy, risk, statin | 3 Comments »
A new article in the May issue of Cancer Epidemiology, Biomarkers and Prevention appears to be a first attempt to project population-based probabilities of the occurrence of clinically significant prostate cancer among men who are diagnosed with prostate cancer but who receive no treatment.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Uncategorized | Tagged: clinical, Diagnosis, insignificant, probability, risk, significant | 5 Comments »
A new analysis of information from the Swedish national prostate cancer registry database and the Swedish cause of death register has confirmed the importance of aggressive, curative treatment of men with locally advanced prostate cancer.
Filed under: Living with Prostate Cancer, Management | Tagged: locally advanced, mortality, prostate cancer-specific, Sweden | 1 Comment »
Search for new and
ongoing trials on the
CTAG PCa web site